Published in Acta Biol Med Ger on January 01, 1979
Monoclonal antibodies neutralizing human leukocyte acid- and thermolabile interferon alpha. Acta Virol (1989) 0.86
An interferon like substance induced by mannans. Acta Virol (1967) 0.85
Differential anti-chemokine activity of Amblyomma variegatum adult ticks during blood-feeding. Parasite Immunol (2007) 0.85
Evasin-3-like anti-chemokine activity in salivary gland extracts of ixodid ticks during blood-feeding: a new target for tick control. Parasite Immunol (2010) 0.84
Double-stranded f 2 phage RNA as interferon inducer. Acta Virol (1971) 0.82
Immunomodulatory arsenal of nymphal ticks. Med Vet Entomol (2008) 0.82
The effect of postfusion cell density on establishment of hybridomas. Folia Biol (Praha) (1988) 0.82
Release of interferon by mouse peritoneal cells in vitro. The requirement of contact with endotoxin and the temperature dependence of release. Acta Virol (1969) 0.81
Electrophoretic profiles and activities of human interferon in heterologous cells. Intervirology (1974) 0.81
Enhancement of neutralizing efficacy by combining three monoclonal antibodies to human interferon-alpha. Immunology (1991) 0.81
Prevention of spontaneous autoimmunity to DNA in NZB/Swiss mice by treatment with natural double-stranded RNA. Immunology (1975) 0.81
Enhancing effect of anti-endotoxic serum on interferon induction in mouse peritoneal cells by endotoxin. Acta Virol (1968) 0.81
Antiplatelet-derived growth factor (PDGF) activity in the saliva of ixodid ticks is linked with their long mouthparts. Parasite Immunol (2014) 0.79
Activation of NK cells in subjects exposed to mild hyper- or hypothermic load. J Interferon Res (1988) 0.79
Periodicity of interferon appearance in serum of patients with systemic lupus erythematosus. Arthritis Rheum (1984) 0.78
Activation of the complement system by interferon inducers. Acta Virol (1972) 0.78
Promotion of vesicular stomatitis virus nucleocapsid protein production by arthopod saliva. Acta Virol (1999) 0.78
Interferon as therapeutic agent. Acta Virol (1983) 0.78
The temperature requirement for interferon production in cells stimulated by Newcastle disease virus or microbial agents in vitro. Acta Virol (1967) 0.78
The reticuloendothelial system and virus infection. II. Production of interferon- and antibody-like substances in mouse peritoneal cells infected with myxoviruses in vivo. Arch Gesamte Virusforsch (1965) 0.78
Antiviral and cell-growth inhibitory activities of highly purified L-cell interferon. An analysis of quantitative disproportions. Acta Virol (1975) 0.78
Preparation and characterization of hybridomas producing monoclonal antibodies against human alpha interferon. Acta Virol (1986) 0.78
Distribution of antiviral and cell-inhibitory activity in interferon preparations. Acta Virol (1972) 0.77
The cell-growth inhibitory effect of interferon. Studies of a resistant cell-subline. Neoplasma (1977) 0.77
Are the acid-labile interferon alpha and interferon omega-1 identical? Virology (1991) 0.77
Affinity chromatography of mouse interferon: a modified purification procedure utilizing specifically purified antibodies. Acta Virol (1976) 0.77
Chemokine-binding activities of M3 protein encoded by Murine gammaherpesvirus 72. Acta Virol (2008) 0.77
Current view on the perspectives of interferon therapy. Acta Virol (1986) 0.77
Therapeutic use of double-stranded RNAs in man. Tex Rep Biol Med (1983) 0.77
Peptide-mapping of three neutralizing epitopes into predicted biologically active sites of human interferon-alpha 2. Immunol Lett (1993) 0.76
Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors. Acta Virol (1989) 0.76
Effect of impulsin treatment of interferon production and antiviral resistance of mice. Arch Immunol Ther Exp (Warsz) (1977) 0.76
Immunodominant structures in the aminoterminal portion of human interferon alpha 1. Mol Immunol (1992) 0.76
[N[2-hydroxyethyl] palmitamide repeated administration effect on interferon production in mouse organism after phage double-stranded ribonucleic acid [ds-RNA] application (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1978) 0.76
Vesicular stomatitis virus nucleocapsid protein production in cells treated with selected fast protein liquid chromatography fractions of tick salivary gland extracts. Acta Virol (2002) 0.75
Interactions between viral infection and immune mechanisms. Comp Immunol Microbiol Infect Dis (1980) 0.75
Use of bacteriophage nucleic acid inducers of interferon in man. Tex Rep Biol Med (1977) 0.75
Accelerated appearance of an ascitic tumour after long-term application of interferon to NZB/W mice. Acta Virol (1981) 0.75
[Interferon 1981. The present state of research and therapeutic utilization (author's transl)]. Cas Lek Cesk (1981) 0.75
[Systems approach to interferon as an anticancer agent]. Zh Mikrobiol Epidemiol Immunobiol (1985) 0.75
Release of an interferon-like virus inhibitor during contact of mouse leukocytes with target cells. Acta Virol (1970) 0.75
Dynamics of serum markers in the different course of hepatitis B virus (HBV) infection. Acta Virol (1987) 0.75
Antiviral and cell-growth inhibitory effect of interferon. Biomedicine (1973) 0.75
[Interferon as a therapeutic agent]. Cesk Farm (1982) 0.75
In vitro antiproliferative effect of interferon alpha in solid tumors: a potential predictive test. Neoplasma (1993) 0.75
Comparison on interferon production in mouse leukocytes by statolon and a complexed polyribonucleotide (poly I:C). Acta Virol (1970) 0.75
Porcine leukocyte interferon exhibits close antigenic relatedness to human interferon alpha 2, but not to human interferon alpha 1. Vet Immunol Immunopathol (1993) 0.75
Distinct effect of pH 2 on a common antigenic structure found in human interferons-alpha 1 and -alpha 2 in the region 30-35. J Interferon Res (1991) 0.75
[Treatment of juvenile papillomatosis of the larynx using interferon and levamisole]. Cesk Otolaryngol (1986) 0.75
Properties of the inferferon-like virus inhibitor released during interaction of mouse sensitized lymphocytes with their target cells. Eur J Immunol (1971) 0.75
Some biological activities of rabbit anti-interferon serum. Acta Virol (1976) 0.75
Production of interferon and other lymphokines during murine tumour growth. II. Induction of an interferon by Ehrlich ascites cells in outbred mice. Acta Virol (1980) 0.75
Modification of the antigenic structure of human interferon alpha-2 by PH 2 treatment: a further support for the antigenic relationship between alpha and beta interferons. Acta Virol (1990) 0.75
Production of interferon and other lymphokines during murine tumour growth. III. Characterization of microbial growth inhibitory activity in cell-free supernatants of rat Zajdela ascites hepatoma. Acta Virol (1982) 0.75
Production of antiviral and migration inhibitory activities in the peritoneum of mice after inoculation with allogenic Ehrlich ascites tumor cells. Acta Biol Med Ger (1979) 0.75
The effect of native and sonicated double-stranded polyribonucleotides on the course of spontaneous autoimmune disease in NZB and NZB/Swiss F1 mice. Acta Virol (1979) 0.75
[A hyperthermic bath increases the cytolytic activity of NK cells]. Cas Lek Cesk (1987) 0.75
Preparation of highly sensitive mouse hybrid cells for interferon assays. J Immunol Methods (1989) 0.75
Monoclonal antibodies neutralizing the antiviral and the antiproliferative activities of human interferon gamma. Acta Virol (1988) 0.75
Effect of cyclophosphamide on the protective action of endotoxin in mice challenged with encephalomyocarditis virus. Acta Virol (1972) 0.75
The effect of interferon induction on complement level in rat. Acta Biol Med Ger (1979) 0.75
[Interferon formation in hairy cell leukemia]. Cas Lek Cesk (1987) 0.75
Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2. Acta Virol (2001) 0.75
Inhibitory effect of interferon on cell fusion by Sendai virus and polyethylene glycol. Acta Virol (1983) 0.75
[Production of gamma interferon and interleukin 2 in mononuclear spleen cells stimulated with concanavalin A]. Vopr Virusol (1985) 0.75
Mercaptoethanol sensitivity of interferons produced in various compartments of the mouse organism. Acta Virol (1966) 0.75
Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illness. Acta Virol (1988) 0.75
Partial heterologous tolerance to interferon production in mice infected with B. pertussis. Acta Virol (1966) 0.75
Surface properties of the egg and mouse lines of A1 influenza virus. J Immunol (1965) 0.75
The interferon system: characterization of intraspecific mouse hybrids. Acta Virol (1982) 0.75
Murine monoclonal antibodies against human fibroblast (beta) interferon. Correlation of the neutralization of antiviral and antiproliferative activities. Acta Virol (1989) 0.75
Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B. Acta Virol (1990) 0.75
Clinical and immunological characterization of systemic lupus erythematosus in patients with circulating interferon and migration inhibitory factor. Int J Clin Pharmacol Res (1984) 0.75
Comparison of the protein profiles of salivary gland extracts derived from three species of unfed and partially fed ixodid ticks analysed by SDS-PAGE. Folia Parasitol (Praha) (2000) 0.75
The cell growth inhibitory and antiviral effects of interferon in cloned transformed mouse cells. Ann N Y Acad Sci (1980) 0.75
Investigations on the effect of the host on certain activities of influenza virus. Acta Virol (1968) 0.75
Preparation and characterization of hybridomas secreting monoclonal antibodies to tick-borne encephalitis virus. Acta Virol (1986) 0.75
The syndrome of adaptation of influenza viruses to laboratory animals. J Hyg Epidemiol Microbiol Immunol (1966) 0.75
[The effect of viruses on the immune system]. Bratisl Lek Listy (1987) 0.75
Relation of incubation temperature to interferon production in mouse peritoneal cells infected with Newcastle disease virus. Acta Virol (1969) 0.75
Interferon-induced changes in the expression and topography of H-2 antigens and receptors for SRBC in tumour cells. Folia Biol (Praha) (1982) 0.75
Production of human leukocyte interferon for clinical use under immunoelectrophoretic control. Acta Biol Med Ger (1979) 0.75
Effect of Mahonia aquifolium stem bark crude extract and one of its polysaccharide components on production of IL-8. Fitoterapia (2001) 0.75
Growth inhibitory effect of mouse interferon in transformed cells. Acta Microbiol Acad Sci Hung (1981) 0.75
Immunological markers in patients with different forms of viral hepatitis B treated by "conventional" therapy or with HuIFN alpha. Acta Virol (1990) 0.75
Therapy-induced antibodies to interferon-alpha 2a recognise its receptor-binding site. Acta Virol (1998) 0.75
Effect of different polyribonucleotides on the induction of antibodies to DNA and RNA and serum complement level in mice. Acta Biol Med Ger (1979) 0.75
Some biological activites of rabbit anti-interferon serum. Arch Immunol Ther Exp (Warsz) (1977) 0.75
Antigenic link between human interferons-alpha and -beta: the common epitope 1. J Interferon Res (1990) 0.75
Diphasic production of secondary metabolites by Penicillium notatum Westling S-52. I. Biosynthesis of eitrinin. Folia Microbiol (Praha) (1973) 0.75
Interferon-like and antibody-like substances in mouse peritoneal cells stimulated by myxoviruses in vivo. Acta Virol (1965) 0.75
Production of interferon and other lymphokines during murine tumour growth. I. Lymphokines in cell--free fluid of rat Zajdela ascites hepatoma. Acta Virol (1980) 0.75
[Interferon. Experiences and perspectives]. Cas Lek Cesk (1968) 0.75
Increased effects of topically applied interferon on herpes simplex virus-induced lesions by caffeine. Acta Virol (1995) 0.75
Some properties of interferon released by mouse peritoneal leukocytes stimulated with endotoxin, mannan and Newcastle disease virus in vitro. Acta Virol (1970) 0.75